Trends in Uterine Cancer Cases After the Coronavirus Disease 2019 (COVID-19) Pandemic
We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.
Authors
- Joshua E. Chan (ORCID: https://orcid.org/0000-0002-6016-1397)
- C. A. Johnson (ORCID: https://orcid.org/0000-0002-0641-7320)
- Kathleen M. Darcy (ORCID: https://orcid.org/0000-0003-2888-2968)
- Chunqiao Tian (ORCID: https://orcid.org/0000-0003-3815-8025)
- Daniel S. Kapp (ORCID: https://orcid.org/0000-0002-3659-3253)
- Cheng-I Liao (ORCID: https://orcid.org/0000-0001-5086-6871)
- John K. C. Chan
- Chelsea Stewart
- Nathan Tran
Institutions
- Henry M. Jackson Foundation (US)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1097/aog.0000000000005731
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Henry M. Jackson Foundation
- National Institutes of Health
- Uniformed Services University of the Health Sciences
- National Institute of Nursing Research